Capital Expenditures for IQVIA (IQV)
According to IQVIA's latest reported financial statements, the company's current capital expenditures (TTM) is $760.00M USD. Capital expenditures (CapEx) are cash outlays for property, plant, and equipment and other long-lived productive assets — reported on the cash flow statement under investing activities. CapEx funds future capacity (factories, data centers, software, machinery), so rising spend can signal investment in growth, while heavy CapEx reduces free cash flow available to shareholders. We display CapEx as a positive amount (the absolute cash outflow); compare with revenue to gauge capital intensity and with total assets for the asset-base context.
Headline TTM above sums the four reported quarters through (reported ). Chart and table below cover the full reported history back to .
IQV
Currently viewingCapital ExpendituresSwitch metric
Latest period
$760.00M
YoY change
+0.2%
5Y CAGR
-0.4%
Peak year (2022)
$674.00M
Cumulative capital expenditures
$5.84B
CapEx history chart for IQVIA (IQV) from 2010 to 2025
CapEx history table for IQVIA (IQV) from 2010 to 2025
| Fiscal year | Period ended | Reported | Capital Expenditures | YoY |
|---|---|---|---|---|
| 2025 | $603.00M | +0.2% | ||
| 2024 | $602.00M | -7.2% | ||
| 2023 | $649.00M | -3.7% | ||
| 2022 | $674.00M | +5.3% | ||
| 2021 | $640.00M | +3.9% | ||
| 2020 | $616.00M | +5.8% | ||
| 2019 | $582.00M | +26.8% | ||
| 2018 | $459.00M | +24.4% | ||
| 2017 | $369.00M | +125.0% | ||
| 2016 | $164.00M | +109.2% | ||
| 2015 | $78.39M | -5.2% | ||
| 2014 | $82.65M | -10.5% | ||
| 2013 | $92.35M | +29.5% | ||
| 2012 | $71.34M | -5.7% | ||
| 2011 | $75.68M | -5.7% | ||
| 2010 | $80.24M | — |
CapEx values are taken from IQVIA's reported cash flow statements (10-Q quarterly and 10-K annual filings with the U.S. Securities and Exchange Commission). Each row shows the period end date and the date the filing was reported; YoY compares each figure to the same period one year earlier. Amounts are in USD as filed.
Analysis
As of the 2025 fiscal year, IQVIA (IQV) reported capital expenditures of $603.00M – edged up 0.2% year-over-year.
IQVIA capital expenditures has contracted on net over the period, with a -0.4% compound annual growth rate over 2020–2025 (5 years).
IQVIA capital expenditures declined from $674.00M in 2022 to $603.00M in 2025, a 10.5% drawdown.
2022 marks the peak capital expenditures at $674.00M, with the historical low of $71.34M recorded in 2012.
Among 8 Healthcare peers, IQVIA (IQV) ranks 9th; the peer median for capital expenditures is $3.87B.
IQVIA Capital Expenditures by Year
IQVIA Capital Expenditures 2025: $603.00M
IQVIA capital expenditures in 2025 was $603.00M, edged up 0.2% from 2024.
IQVIA Capital Expenditures 2024: $602.00M
IQVIA capital expenditures in 2024 was $602.00M, declined 7.2% below 2023.
IQVIA Capital Expenditures 2023: $649.00M
IQVIA capital expenditures in 2023 was $649.00M, edged down 3.7% below 2022.
IQVIA Capital Expenditures 2022: $674.00M
IQVIA capital expenditures in 2022 was $674.00M, grew 5.3% from 2021. This figure represents the highest annual value in the available history.
IQVIA Capital Expenditures 2021: $640.00M
IQVIA capital expenditures in 2021 was $640.00M.
See more financial history for IQVIA (IQV).
Sector peers — CapEx
Companies in the same sector as IQVIA, ranked by their latest capital expenditures.
| Company | Capital Expenditures | Sector |
|---|---|---|
| Novo Nordisk A/S (NVO) | $90.11B | Healthcare |
| Eli Lilly and Company (LLY) | $7.84B | Healthcare |
| Johnson & Johnson (JNJ) | $4.83B | Healthcare |
| Merck & Co., Inc. (MRK) | $4.11B | Healthcare |
| UnitedHealth Group Incorporated (UNH) | $3.62B | Healthcare |
| AstraZeneca PLC (AZN) | $2.81B | Healthcare |
| Amgen Inc. (AMGN) | $1.86B | Healthcare |
| AbbVie Inc. (ABBV) | $1.21B | Healthcare |
Frequently asked questions
What is IQVIA's capital expenditures?
- Latest reported capital expenditures for IQVIA (IQV) is $760.00M (period ending December 31, 2025).
How has IQVIA capital expenditures changed year-over-year?
- IQVIA (IQV) capital expenditures changed +0.2% year-over-year on the latest annual filing.
What is the long-term growth rate of IQVIA capital expenditures?
- IQVIA (IQV) capital expenditures compound annual growth rate is -0.4% over the most recent 5 years available.
When did IQVIA capital expenditures hit its highest annual value?
- IQVIA capital expenditures reached its highest annual value of $674.00M in 2022.
What was IQVIA capital expenditures in 2024?
- IQVIA (IQV) capital expenditures in 2024 was $602.00M.
What was IQVIA capital expenditures in 2025?
- IQVIA (IQV) capital expenditures in 2025 was $603.00M.
Metrics overview
Pick a metric for charts, filings, and peers — each row shows the latest TTM or annual value with year-over-year change.
Explore more
IQV Overview
Company profile, financial tools, and key metrics
IQV Revenue Counter
Earns $517.19 every second. See per minute, hour, and day.
IQV Earnings Counter
Earns $43.13 per second net profit. See per minute, hour, and day.
IQV Economic Scale
Exceeds Bahamas, The's GDP. Compare with world economies.
IQV What If Invested
What if you had invested $1,000? See historical returns from any date.
IQV How It Makes Money
Discover visual breakdown of $16.31B in revenue — where it comes from and where it goes.
IQV Stock Seasonality
Best and worst months to invest. Historical monthly returns heatmap.
IQV Price Target Scenarios
Model bear, base, and bull cases with EPS growth and exit P/E — pre-filled from analysts and history.
IQV Daily Price Character
Steady · 51.4% historical win rate (green days). Streaks & record days.
IQV Buybacks
5.94% TTM buyback yield. Shareholder yield & SBC comparison.